Atom Investors’s Exact Sciences EXAS Stock Holding History

Atom Investors’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-21,418	Closed	-$1.24M	–	418
2020 Q1	$1.24M	Buy	+21,418	New	+$1.74M	0.11%	145
2019 Q4	–	Sell	-68,027	Closed	-$6.15M	–	255
2019 Q3	$6.15M	Buy	+68,027	New	+$7.75M	0.42%	85
2019 Q2	–	Sell	-12,044	Closed	-$1.04M	–	471
2019 Q1	$1.04M	Buy	+12,044	New	+$1.03M	0.09%	175

Other funds holding EXAS

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Atom Investors's EXAS Position: Q2 2020 in Review

Atom Investors sold out of Exact Sciences (EXAS) in Q2 2020, closing a stake of 21,418 shares — an estimated $1.24M sold.

Atom Investors first reported a position in EXAS in Q1 2019 and held it in 3 quarters. The position peaked at $6.15M in Q3 2019. 513 funds tracked by Wall St. Rank hold EXAS as of Q2 2020.

Atom Investors reported no remaining Exact Sciences position as of Q2 2020 after selling out during the quarter.
Atom Investors sold 21,418 Exact Sciences shares in Q2 2020, an estimated $1.24M.
Atom Investors first reported a position in Exact Sciences in Q1 2019 and held it in 3 quarters.
Atom Investors's Exact Sciences position peaked at $6.15M in Q3 2019.
513 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2020.

Based on Atom Investors's 13F filing for Q2 2020, filed 14 Aug 2020.